UK Explains Approach To Renewing Converted EU Drug Approvals in 2021

 
• By Vibha Sharma

The Medicines and Healthcare products Regulatory Agency has put procedures in place to renew UK marketing authorizations that are grandfathered from the EU system after the Brexit transition period ends.

Broken chain
MHRA will be the UK’s standalone medicines regulator From 1 January 2021 • Source: Shutterstock

More from United Kingdom

More from Europe